Navigating the Medicare Maze
On September 28, 2016, the Life Raft Group was pleased to have Melissa Simpson, Senior Program Manager in the Center for Benefits Access at the National Council on Aging share her knowledge and insight [...]
Examining Kidney Toxicities of Sunitinib and Imatinib in Long-Term GIST Therapy
On September 19, 2016 the Life Raft Group was pleased to have Dr. Benjamin D. Humphreys, Chief of the Division of Nephrology at Washington University in St. Louis School of Medicine, share his knowledge [...]
Webcast Provides Perspective on Generic Imatinib
On February 1, 2016, the commercial launch of the generic version of imatinib mesylate (Gleevec), originally for CML (Chronic Myeloid Leukemia), was approved by the FDA and became available for the first time in the United States through Sun Pharmaceuticals. In response to this transition, the LRG provided an educational Webinar to the CML and GIST communities on March 18th entitled “Generic Imatinib: Gaining Perspective.”